Philip Astley Sparke Replimune Group, Inc. (REPL) insider trading activity

Philip Astley Sparke is Director of Replimune Group, Inc.. Currently has a direct ownership of 1.41 Million shares of REPL, which is worth approximately $12.6 Million. The most recent transaction as insider was on May 20, 2025, when has been sold 32,279 shares (Common Stock) at a price of $8.06 per share, resulting in proceeds of $260,168. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.41M

2.25% 3M change

5.53% 12M change

Total Value Held $12.6 Million

Philip Astley-Sparke Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 20 2025	SELL Open market or private sale	$260,168 $8.06 p/Share	32,279 Reduced 2.25%	1,405,071 Common Stock
Aug 30 2024	SELL Bona fide gift	-	50,000 Reduced 3.36%	1,437,350 Common Stock
May 16 2024	SELL Open market or private sale	$245,394 $6.47 p/Share	37,928 Reduced 2.49%	1,487,350 Common Stock
May 16 2023	SELL Open market or private sale	$323,131 $18.05 p/Share	17,902 Reduced 1.16%	1,525,278 Common Stock
Apr 01 2023	BUY Grant, award, or other acquisition	-	142,100 Added 8.43%	1,543,180 Common Stock
May 16 2022	SELL Open market or private sale	$140,531 $14.59 p/Share	9,632 Reduced 0.68%	1,401,080 Common Stock
Apr 01 2022	BUY Grant, award, or other acquisition	-	70,000 Added 4.73%	1,410,712 Common Stock
Apr 01 2021	BUY Grant, award, or other acquisition	-	85,415 Added 5.99%	1,340,712 Common Stock
Jan 19 2021	SELL Open market or private sale	$360,721 $42.78 p/Share	8,432 Reduced 0.67%	1,255,297 Common Stock
Jan 15 2021	SELL Open market or private sale	$727,170 $43.89 p/Share	16,568 Reduced 1.29%	1,263,729 Common Stock
Jan 14 2021	SELL Open market or private sale	$1,095,500 $43.82 p/Share	25,000 Reduced 1.92%	1,280,297 Common Stock
Dec 10 2020	SELL Open market or private sale	$1,075,750 $43.03 p/Share	25,000 Reduced 1.88%	1,305,297 Common Stock
Dec 09 2020	SELL Open market or private sale	$1,098,250 $43.93 p/Share	25,000 Reduced 1.84%	1,330,297 Common Stock

Also insider at

QURE

uniQure N.V. Healthcare

Director